MutualFundWire.com: Two Years, Three Funds, $500MM In AUM

MutualFundWire.com

The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication

Wednesday, August 19, 2020

Two Years, Three Funds, $500MM In AUM

Two years in, the team at New York City-based Defiance ETFs has crossed the $500 million AUM milestone.

Matthew Ross Bielski
Defiance ETFs, LLC
Founder, CEO

"Despite a global pandemic that has generated uncertainties across many sectors, we have continued to bring innovative first-to-market ETFs that are in high demand by both retail and institutional investors," Matt Bielski , Defiance's CEO, stated. They celebrated by ringing the Nasdaq closing bell yesterday.

Earlier this month, the Defiance team unveiled their third ETF, the Defiance Nasdaq Junior Biotechnology ETF (IBBJ). This ETF tracks small to mid-cap biotech companies, or those with a market capitalization of below $5 billion.

Defiance ETFs was founded in 2018 by Bielski after his previous experiences at ProShares, BlackRock, and Direxion. The firm crossed the $100 million AUM line last year.

Printed from: MFWire.com/story.asp?s=61764

Copyright 2020, InvestmentWires, Inc.
All Rights Reserved